BKNG(BKNG)
BKNG
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $29.39B | $32.11B | $34.74B | $37.70B | $40.06B |
| Low | $29.06B | $31.52B | $34.73B | $36.92B | $39.23B |
| High | $29.86B | $32.75B | $34.75B | $38.51B | $40.92B |
| EBITDA Avg | $14.37B | $15.70B | $16.99B | $18.44B | $19.59B |
| Low | $14.21B | $15.41B | $16.99B | $18.06B | $19.19B |
| High | $14.60B | $16.02B | $16.99B | $18.83B | $20.01B |
| EBIT Avg | $14.10B | $15.40B | $16.66B | $18.08B | $19.21B |
| Low | $13.94B | $15.11B | $16.66B | $17.71B | $18.82B |
| High | $14.32B | $15.70B | $16.66B | $18.47B | $19.62B |
| Net Income Avg | $8.18B | $10.04B | $11.81B | $14.06B | $15.80B |
| Low | $8.16B | $9.77B | $11.15B | $13.68B | $15.38B |
| High | $8.82B | $10.30B | $12.47B | $14.45B | $16.24B |
| EPS Avg | $10.44 | $12.33 | $14.35 | $17.23 | $19.37 |
| Low | $10.00 | $11.98 | $13.66 | $16.77 | $18.85 |
| High | $10.80 | $12.63 | $15.29 | $17.71 | $19.91 |
| Analysts (Rev / EPS) | 26 / 23 | 27 / 23 | 18 / 13 | 11 / 11 | 9 / 5 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $9.74B | $6.88B | $6.00B | $8.03B | $10.56B | $7.49B | $6.59B | $8.19B |
| Low | $9.55B | $6.70B | $5.84B | $7.82B | $10.29B | $7.30B | $6.42B | $7.98B |
| High | $10.12B | $7.17B | $6.25B | $8.37B | $11.00B | $7.81B | $6.87B | $8.53B |
| EBITDA Avg | $4.76B | $3.37B | $2.93B | $3.93B | $5.17B | $3.67B | $3.22B | $4.01B |
| Low | $4.67B | $3.28B | $2.86B | $3.83B | $5.03B | $3.57B | $3.14B | $3.90B |
| High | $4.95B | $3.51B | $3.05B | $4.09B | $5.38B | $3.82B | $3.36B | $4.17B |
| EBIT Avg | $4.67B | $3.30B | $2.88B | $3.85B | $5.07B | $3.59B | $3.16B | $3.93B |
| Low | $4.58B | $3.22B | $2.80B | $3.75B | $4.93B | $3.50B | $3.08B | $3.83B |
| High | $4.85B | $3.44B | $3.00B | $4.01B | $5.28B | $3.74B | $3.29B | $4.09B |
| Net Income Avg | $3.61B | $1.85B | $1.10B | $2.28B | $4.13B | $2.13B | $1.31B | $2.61B |
| Low | $3.57B | $1.79B | $1.06B | $2.20B | $3.99B | $2.06B | $1.27B | $2.53B |
| High | $3.67B | $1.95B | $1.16B | $2.40B | $4.35B | $2.25B | $1.38B | $2.76B |
| EPS Avg | $4.55 | $2.33 | $1.39 | $2.87 | $5.20 | $2.69 | $1.65 | $3.29 |
| Low | $4.49 | $2.25 | $1.34 | $2.77 | $5.02 | $2.60 | $1.60 | $3.18 |
| High | $4.62 | $2.45 | $1.46 | $3.02 | $5.48 | $2.83 | $1.74 | $3.47 |
| Analysts (Rev / EPS) | 18 / 14 | 17 / 10 | 9 / 10 | 9 / 6 | 14 / 7 | 9 / 6 | 8 / 7 | 11 / 7 |